What is the recommended workup for a patient presenting with telangiectasias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Telangiectasia

The recommended workup for a patient presenting with telangiectasias should include assessment for nasal and oral mucosal telangiectasias, family history of recurrent nosebleeds, and evaluation for potential underlying systemic disorders, particularly hereditary hemorrhagic telangiectasia (HHT). 1

Initial Assessment

  • Location and distribution pattern: Document whether telangiectasias are localized or generalized, as this helps distinguish between primary and secondary causes 2
  • Associated symptoms: Assess for:
    • Recurrent epistaxis (nosebleeds), especially if bilateral
    • Gastrointestinal bleeding
    • Neurological symptoms
    • Respiratory symptoms
    • Family history of similar lesions or bleeding
  • Physical examination: Carefully examine:
    • Nasal mucosa (anterior rhinoscopy)
    • Oral mucosa
    • Skin (face, hands, trunk)
    • Conjunctiva

Diagnostic Algorithm

Step 1: Screen for HHT

If the patient has recurrent bilateral nosebleeds or family history of recurrent nosebleeds:

  • Perform detailed examination for telangiectasias in nasal and oral mucosa 1
  • Apply Curaçao criteria for HHT diagnosis 1:
    • Recurrent spontaneous epistaxis
    • Multiple telangiectasias at characteristic sites (lips, oral cavity, fingers, nose)
    • Visceral lesions (gastrointestinal, pulmonary, cerebral, spinal)
    • Family history of HHT in first-degree relative

Step 2: Evaluate for Secondary Causes

If HHT is not suspected, assess for:

  • Medication history (especially anticoagulants)
  • History of radiation therapy 1
  • Liver disease
  • Connective tissue disorders
  • Ataxia telangiectasia (if neurological symptoms present) 1
  • Malignancy (especially cutaneous lymphoma) 2

Step 3: Laboratory Testing

  • Complete blood count (to assess for anemia)
  • Coagulation studies
  • Liver function tests
  • Consider genetic testing for HHT (ENG, ACVRL1, SMAD4) in patients with suspected HHT 1

Step 4: Additional Imaging Based on Clinical Suspicion

For patients with suspected HHT:

  • Contrast echocardiography to screen for pulmonary arteriovenous malformations
  • Brain MRI to screen for cerebral vascular malformations
  • Abdominal imaging to assess for liver vascular malformations

For patients with suspected ataxia telangiectasia:

  • Chest imaging if respiratory symptoms are present 1

Special Considerations

Anticoagulated Patients

  • For patients on anticoagulants with telangiectasia-related bleeding, consult with the clinician managing anticoagulation before modifying medication regimen 1, 3
  • For non-severe bleeding, do not reverse anticoagulation if bleeding can be otherwise controlled 1

Referral Indications

  • Refer to HHT specialist center if HHT is suspected 1
  • Refer to hematology if bleeding is severe or recurrent
  • Refer to dermatology for extensive cutaneous telangiectasias without clear cause
  • Refer to neurology if ataxia or other neurological symptoms are present 1

Pitfalls to Avoid

  • Don't assume all telangiectasias are benign: They can be markers of serious underlying conditions including malignancy 4
  • Don't miss HHT diagnosis: HHT is underdiagnosed with significant diagnostic delays 1
  • Don't immediately reverse anticoagulation: In non-severe bleeding, first-line treatments should be initiated prior to reversal of anticoagulation 1
  • Don't forget age-related considerations: The appearance of telangiectasias in HHT has age-related expression 1

By following this structured approach to the workup of telangiectasias, clinicians can efficiently identify underlying causes and initiate appropriate management or referral for these patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A clinical approach to diagnose patients with localized telangiectasia.

International journal of dermatology, 2015

Guideline

Treatment of Telangiectasia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Telangiectasias: Small lesions referring to serious disorders.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.